Wu, Bogang
@bogang_wu
Followers
69
Following
142
Statuses
43
Incoming Assistant Professor @MayoClinic; NCI K99/R00 Fellow; Tumor Immunologist @MGHCancerCenter & @HarvardMed; graduated from @GWSMHS
Boston, MA
Joined December 2016
Thrilled to announce that I’ll start my independent laboratory as an Assistant Professor in the Department of Immunology at @MayoClinic next summer! My lab will focus on tumor immunology, regulation of immune cell function, and translational research in immune pathophysiology.
4
0
15
0
0
1
@IlariaG32 @CD_AACR @FibroFoundation @AICF_nyc @DonaBertarelli @ForbeckForums @AlexLemonade Congratulations Ilaria! Beautiful work!
0
0
1
I'm excited to be speaking at AACR Special Conference in Cancer Research: Tumor Immunology and Immunotherapy on TNBC immune microenvironment. Join me for engaging presentations, networking opportunities, and discussions of the future of the field. @AACR
0
0
2
@ChiappinelliLab @MayoClinic Thank you so much Dr. Chiappinelli for your incredible support in this journey!
0
0
0
I’m deeply grateful to all my mentors and colleagues from @GW_IBS @MGHCancerCenter @harvardmed for their tremendous support and appreciate the funding from @TBBCF and @theNCI. The Wu lab will be recruiting at all levels, so please stay tuned or contact me directly if interested.
0
0
1
Beautiful story! Congratulations Mengju!
New in @sciencemagazine! Our study reveals how mutant IDH1 inhibition activates tumor immunity by inducing dsDNA sensing. Read more: #CancerResearch #Cholangiocarcinoma #IDH1 1/n
0
0
0
RT @DFCI_BreastOnc: New study now out in @CCR_AACR 👇 #AntibodyDrugConjugate Sacituzumab Govitecan Enables A Sequential TOP1/PARP Inhibitor…
0
9
0
Thrilled to join the MGB Commercialization and Inclusive Leadership Program! This initiative is all about creating an inclusive innovation ecosystem, exploring commercialization opportunities, and fostering community building. Let's drive change together!#CILP2024 @MGBInnovation
0
0
2
0
0
1
RT @dradityabardia: Antibody Drug Conjugate, SG, enables sequential TOP1/PARP inhibitor strategy & highlights need to revisit previously ab…
0
7
0
RT @MammaryCell: 🥼 In a new @CCR_AACR study led by @dradityabardia and Dr. Leif Ellisen, the proof-of-mechanism and 🩺 clinical feasibility…
0
2
0
I'm excited to be speaking at IMMUNOLOGY2024™ on epigenetic regulation of antitumor T cell functionality! Join me for engaging presentations, networking opportunities, and discussions on the future of the field. #AAI2024 #immunology
0
0
3
RT @Ludwig_Cancer: Ludwig @harvardmed's @bogang_wu presented at #AACR24 his research into the systematic identification of biochemical path…
0
3
0